1
项与 Myeloid dendritic cells(Radboud University) 相关的临床试验A Randomized Phase IIa Study: Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer Patients
Prostate cancer is the only type of cancer in which conventional dendritic cells (DC) treatment has a beneficial effect on the overall survival. In this study investigators aim to show immunologic efficacy of tumor-peptide loaded natural DC in metastatic castration-resistant prostate cancer patients (mCRPC).
The immunomonitoring will include:
functional response and tetramer analysis of delayed-type hypersensitivity infiltrating lymphocytes against tumor peptides and
type I interferon (IFN) gene expression in peripheral blood mononuclear cells, and
proliferative, effector cytokine- and humoral responses to keyhole limpet hemocyanin, a immunogenic protein providing T cell help.
The secondary objectives are the safety and feasibility of natural DC vaccinations, the influence on the quality of life during treatment with natural DC, and the clinical efficacy of treatment.
100 项与 Myeloid dendritic cells(Radboud University) 相关的临床结果
100 项与 Myeloid dendritic cells(Radboud University) 相关的转化医学
100 项与 Myeloid dendritic cells(Radboud University) 相关的专利(医药)
100 项与 Myeloid dendritic cells(Radboud University) 相关的药物交易